# | Drug | Count |
---|---|---|
0 | FLUDARABINE PHOSPHATE | 332 |
1 | MYCOPHENOLATE MOFETIL | 329 |
2 | TACROLIMUS | 306 |
3 | METHOTREXATE SODIUM | 298 |
4 | METHOTREXATE | 288 |
5 | CYCLOSPORINE | 266 |
6 | TACROLIMUS CAPSULES | 240 |
7 | CYCLOPHOSPHAMIDE | 227 |
8 | BUSULFAN | 213 |
9 | METHYLPREDNISOLONE | 183 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | NEOMYCIN SULFATE, TITRATED EXT. OF CENTELLA ASIATICA | 1 | 0.1667 |
1 | ANTI-FUNGAL LIQUID MAXIMUM STRENGTH | 3 | 0.0227 |
2 | THIOTEPA | 115 | 0.0203 |
3 | BUSULFAN | 213 | 0.0170 |
4 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 83 | 0.0136 |
5 | FLUDARABINE PHOSPHATE | 332 | 0.0130 |
6 | BRINCIDOFOVIR | 1 | 0.0127 |
7 | IBRITUMOMAB TIUXETAN | 18 | 0.0125 |
8 | AMIFOSTINE | 8 | 0.0104 |
9 | FOSCARNET SODIUM | 27 | 0.0101 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Immunoglobulin G [EPC] | 83 | 0.0136 |
1 | Echinocandin Antifungal [EPC] | 44 | 0.0093 |
2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 9 | 0.0083 |
3 | CD52-directed Cytolytic Antibody [EPC] | 85 | 0.0053 |
4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 56 | 0.0043 |
5 | Chemokine Receptor Type 4 Interaction [EPC] | 3 | 0.0043 |
6 | Antimetabolite Immunosuppressant [EPC] | 32 | 0.0037 |
7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 267 | 0.0035 |
8 | Alkylating Drug [EPC] | 496 | 0.0030 |
9 | Lipid-based Polyene Antifungal [EPC] | 28 | 0.0024 |